Showing results (421-430 of 794) with videos related to
Sort By:
Pageof 80
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trialMichael S Braun, Susan D Richman, Lindsay Thompson, et al.Antiviral Research|August 13, 2013
Differential gene expression in HIV-infected individuals following ARTMarta Massanella, Akul Singhania, Nadejda Beliakova-Bethell, et al.AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.Annals of Internal Medicine|February 24, 2001
Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment NetworkE S Daar, S Little, J Pitt, et al.Journal of Virology|March 21, 2008
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infectionSusan J Little, Simon D W Frost, Joseph K Wong, et al.Laboratory Medicine|January 21, 2014
The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of MycobacteriaJoseph Jeong, Sung-Ryul Kim, Seon Ho Lee, et al.AIDS (London, England)|December 3, 2009
Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recoveryChristopher H Woelk, Nadejda Beliakova-Bethell, Miguel Goicoechea, et al.Journal of Virology|December 23, 2004
Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strainsOtto O Yang, Eric S Daar, Beth D Jamieson, et al.Antiviral Research|June 1, 1996
Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitroK Y Hostetler, G D Kini, J R Beadle, et al.Pageof 80